[TREATING VASOMOTOR RHINITIS WITH PSYCHOPHARMACEUTICAL DRUGS].
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The term VMR is used to describe a nonimmunologic, noninfectious, chronic type of rhinitis without nasal eosinophilia. The causes are diverse and, in many cases, never identified. Before the diagnosis of VMR can be made, AR and ENR must be ruled out. A thorough history and physical examination in association with appropriate laboratory testing can be used to distinguish these types of rhinitis. Surgical procedures tend to provide the most relief, but should only be used after more conservative measures have failed.
Explore the source record for details and available documents.
Twenty-six patients with perennial rhinorrhea were treated by Atrovent, the anticholinergic agent, or placebo in a randomized double-blind crossover trial. The severity and duration of rhinorrhea were significantly reduced by Atrovent. Local side effects were more frequent with the active drug. These were reduced in a later open trial by a reduction in dosage.
Explore the source record for details and available documents.
Explore the source record for details and available documents.